We enable value creative business development & licensing transactions.

Client Profile

Our clients want to transfer rights to technology platforms, product portfolios, or individual compounds, to other players that possess unique expertise or strengths in development or commercialisation, and that can realize the potential of our clients’ assets.

Clients often want to access new technology platforms, enter new therapeutic areas or business verticals, reach into new markets, or strengthen their geographic footprint through in-licensing.

Service Offering

We serve licensors by engaging the most attractive partners and understanding their drivers to transact. For licensees, we “unlock” value-accretive opportunities.

We provide multi-disciplinary advice that help resolve upfront any hurdles from across a full range of relevant aspects, which may otherwise arise during a licensing process.

Out-licensing

Typical workstreams in an out-licensing process we advise on include:

  • defining the transaction perimeter (i.e. what is being licensed, potentially including an analysis of several alternatives) and transaction objectives
  • defining the scope of the license and any broader partnership items (IP, infrastructure, staff, manufacturing)
  • preparing the transaction perimeter to withstand diligence
  • identifying potential licensees/ partners
  • crafting an attractive investment thesis for potential licensees to engage
  • assessing each potential licensee and understanding the drivers of each party to engage
  • approaching the licensees in a tailored way with a view to maximize transaction likelihood
  • managing the transaction process, e.g. including the staged release of information, responding to diligence requests, analysing and understanding offers received, and representing information internally within our client to appropriate committees
  • negotiating the financial terms of the license, and other commercial transaction terms
  • negotiation of inter-company agreements (e.g. transition services, manufacturing, quality, etc.)
  • overseeing the closing of the transaction

In-licensing

Typical workstreams in an in-licensing process we advise on include:

  • defining the transaction objectives
  • identifying potential licensing targets, and assessing each opportunity against defined objectives from various perspectives (including strategic value, commercial potential, financial impact, and transactability)
  • approaching the owners of the targets in a tailored way with a view to maximize transaction likelihood
  • managing the transaction process, e.g. including the gathering of disclosure, formulating diligence requests, conducting various types of analyses, and representing findings internally to appropriate committees
  • devising appropriate internal action plans to realize the potential of the licensed assets
  • negotiation of the financial terms of the license and of other commercial transaction terms
  • negotiation of inter-company agreements (e.g. transition services, manufacturing, quality, etc.)
  • overseeing the closing of the transaction

Unique Value Proposition

  • Insight. We deliver a close understanding of the various motivations of potential counterparties, their prerequisites to engage in and consummate a transaction, as well as their adopted negotiation behavior.
  • Best shot. We conduct comprehensive preparation in advance of marketing a transaction opportunity, that pre-addresses diligence requirements and focuses specifically at resolving any gating issues well in advance of “being in the room” with a counterparty.
  • Efficiency. We help focus activities on interactions that have a high likelihood for a transaction; which means we will be very specific in our transaction objectives, be upfront with counterparties on requirements and goals, and avoid entertaining discussions that counterparty individuals engage in merely to internally demonstrate activity.
  • Certainty. We rigorously negotiate licensing agreements to achieve precision and clarity, in order to ensure each side has a common understanding of objectives, obligations and rewards. We eliminate loopholes that may create room for a party to circumvent agreed obligations.
  • Sustainability. In all the transactions we advise on, we focus on achieving a licensing deal with the best partner long-term, as opposed to one with the highest upfront payment where milestones and royalties may never materialize.

The Treehill Difference

  • Multi-disciplinary perspectives. We combine multi-disciplinary perspectives from across science and medicine, corporate and operational leadership, and transaction advisory.
  • Understanding of counterparties. We understand counterparty motivations and behaviour intimately from decades of deal-making experience as corporate leaders, large-cap executives, advisors and investors.
  • Bespoke process. We pride ourselves in rigorous preparation to a depth that we believe is unmatched in the industry. For example, we define future development programs, support IP strategies, and frame market access work. In addition, we employ a proprietary approach strategy to potential counterparties.
  • Proprietary opportunities. From within our network, we have preferential access to off-market opportunities which we may be able to engage in for our clients if there is a strategic match.

Focus of Activities

We provide BD&L services concerning assets at all stages of product development, from preclinical work through to on-market product. We do not work on assets at the stage of basic research.

Context

We implement value-maximizing licensings.  We serve licensors by engaging the most attractive partners and understanding their drivers to transact. For licensees, we “unlock” value accretive opportunities. This 2-minute survey will help us understand to what extent Outsourced Business Development is right for you.

Take our simple questionnaire